Bilateral ulna fractures associated with bisphosphonate therapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22903294.
- Also identified by DOI 10.1007/s00198-012-2118-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of bilateral ulna stress fractures following bilateral femoral fractures associated with long-term bisphosphonate use. The patient is an 84-year-old woman receiving 15 years of bisphosphonate therapy. She did not have any preexisting medical conditions which are known secondary causes of bone loss. She was mostly housebound and used a walking frame for ambulation. She presented with atraumatic right ulna pain and subsequent atraumatic left ulna pain a month later. She was treated conservatively in backslabs and her bisphosphonate was stopped. Investigations did not reveal any secondary causes of osteoporosis or metabolic bone disorders.
Medical subject headings
- Alendronate
- Bone Density Conservation Agents
- Fractures, Stress
- Ulna Fractures